 | • レポートコード：GIR-105X12621 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、新規経口抗凝固薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。新規経口抗凝固薬の種類別市場規模（直接トロンビン阻害剤、第Xa因子阻害剤）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・新規経口抗凝固薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bristol-Myers Squibb、Bayer、Pfizer、Johnson & Johnson、Boehringer Ingelheim、Daiichi Sankyo ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：直接トロンビン阻害剤、第Xa因子阻害剤 ・用途別分析2016年-2026年：病院、ドラッグストア、その他 ・新規経口抗凝固薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・新規経口抗凝固薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・新規経口抗凝固薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・新規経口抗凝固薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・新規経口抗凝固薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Novel Oral Anticoagulants Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Novel Oral Anticoagulants Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Novel Oral Anticoagulants Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Novel Oral Anticoagulants Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Direct Thrombin Inhibitor
Factor Xa Inhibitors
Market segment by Application can be divided into
Hospital
Drugs Stores
Other
The key market players for global Novel Oral Anticoagulants Drugs market are listed below:
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Novel Oral Anticoagulants Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Novel Oral Anticoagulants Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Direct Thrombin Inhibitor
1.2.3 Factor Xa Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Novel Oral Anticoagulants Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Global Novel Oral Anticoagulants Drugs Market Size & Forecast
1.4.1 Global Novel Oral Anticoagulants Drugs Sales in Value (2016-2026))
1.4.2 Global Novel Oral Anticoagulants Drugs Sales in Volume (2016-2026)
1.4.3 Global Novel Oral Anticoagulants Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Novel Oral Anticoagulants Drugs Production Capacity Analysis
1.5.1 Global Novel Oral Anticoagulants Drugs Total Production Capacity (2016-2026)
1.5.2 Global Novel Oral Anticoagulants Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Novel Oral Anticoagulants Drugs Market Drivers
1.6.2 Novel Oral Anticoagulants Drugs Market Restraints
1.6.3 Novel Oral Anticoagulants Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product and Services
2.1.4 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Novel Oral Anticoagulants Drugs Product and Services
2.2.4 Bayer Novel Oral Anticoagulants Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Novel Oral Anticoagulants Drugs Product and Services
2.3.4 Pfizer Novel Oral Anticoagulants Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Novel Oral Anticoagulants Drugs Product and Services
2.4.4 Johnson & Johnson Novel Oral Anticoagulants Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product and Services
2.5.4 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Daiichi Sankyo
2.6.1 Daiichi Sankyo Details
2.6.2 Daiichi Sankyo Major Business
2.6.3 Daiichi Sankyo Novel Oral Anticoagulants Drugs Product and Services
2.6.4 Daiichi Sankyo Novel Oral Anticoagulants Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Novel Oral Anticoagulants Drugs Sales by Manufacturer
3.1 Global Novel Oral Anticoagulants Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Novel Oral Anticoagulants Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Novel Oral Anticoagulants Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Novel Oral Anticoagulants Drugs Manufacturer Market Share
3.4.2 Top 6 Novel Oral Anticoagulants Drugs Manufacturer Market Share
3.5 Global Novel Oral Anticoagulants Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Novel Oral Anticoagulants Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Novel Oral Anticoagulants Drugs Market Size by Region
4.1.1 Global Novel Oral Anticoagulants Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Novel Oral Anticoagulants Drugs Revenue by Region (2016-2026)
4.2 North America Novel Oral Anticoagulants Drugs Revenue (2016-2026)
4.3 Europe Novel Oral Anticoagulants Drugs Revenue (2016-2026)
4.4 Asia-Pacific Novel Oral Anticoagulants Drugs Revenue (2016-2026)
4.5 South America Novel Oral Anticoagulants Drugs Revenue (2016-2026)
4.6 Middle East and Africa Novel Oral Anticoagulants Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Novel Oral Anticoagulants Drugs Sales in Volume by Type (2016-2026)
5.2 Global Novel Oral Anticoagulants Drugs Revenue by Type (2016-2026)
5.3 Global Novel Oral Anticoagulants Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Novel Oral Anticoagulants Drugs Sales in Volume by Application (2016-2026)
6.2 Global Novel Oral Anticoagulants Drugs Revenue by Application (2016-2026)
6.3 Global Novel Oral Anticoagulants Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Novel Oral Anticoagulants Drugs Sales by Type (2016-2026)
7.2 North America Novel Oral Anticoagulants Drugs Sales by Application (2016-2026)
7.3 North America Novel Oral Anticoagulants Drugs Market Size by Country
7.3.1 North America Novel Oral Anticoagulants Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Novel Oral Anticoagulants Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Novel Oral Anticoagulants Drugs Sales by Type (2016-2026)
8.2 Europe Novel Oral Anticoagulants Drugs Sales by Application (2016-2026)
8.3 Europe Novel Oral Anticoagulants Drugs Market Size by Country
8.3.1 Europe Novel Oral Anticoagulants Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Novel Oral Anticoagulants Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region
9.3.1 Asia-Pacific Novel Oral Anticoagulants Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Novel Oral Anticoagulants Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Novel Oral Anticoagulants Drugs Sales by Type (2016-2026)
10.2 South America Novel Oral Anticoagulants Drugs Sales by Application (2016-2026)
10.3 South America Novel Oral Anticoagulants Drugs Market Size by Country
10.3.1 South America Novel Oral Anticoagulants Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Novel Oral Anticoagulants Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country
11.3.1 Middle East & Africa Novel Oral Anticoagulants Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Novel Oral Anticoagulants Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Novel Oral Anticoagulants Drugs Typical Distributors
12.3 Novel Oral Anticoagulants Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Novel Oral Anticoagulants Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Novel Oral Anticoagulants Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product and Services
Table 6. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Novel Oral Anticoagulants Drugs Product and Services
Table 10. Bayer Novel Oral Anticoagulants Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Novel Oral Anticoagulants Drugs Product and Services
Table 14. Pfizer Novel Oral Anticoagulants Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Novel Oral Anticoagulants Drugs Product and Services
Table 18. Johnson & Johnson Novel Oral Anticoagulants Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product and Services
Table 22. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 24. Daiichi Sankyo Major Business
Table 25. Daiichi Sankyo Novel Oral Anticoagulants Drugs Product and Services
Table 26. Daiichi Sankyo Novel Oral Anticoagulants Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Novel Oral Anticoagulants Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 28. Global Novel Oral Anticoagulants Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Novel Oral Anticoagulants Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Novel Oral Anticoagulants Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 31. Head Office and Novel Oral Anticoagulants Drugs Production Site of Key Manufacturer
Table 32. Global Novel Oral Anticoagulants Drugs Sales by Region (2016-2021e) & (K MT)
Table 33. Global Novel Oral Anticoagulants Drugs Sales by Region (2021-2026) & (K MT)
Table 34. Global Novel Oral Anticoagulants Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Novel Oral Anticoagulants Drugs Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Novel Oral Anticoagulants Drugs Sales by Type (2016-2021e) & (K MT)
Table 37. Global Novel Oral Anticoagulants Drugs Sales by Type (2021-2026) & (K MT)
Table 38. Global Novel Oral Anticoagulants Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Novel Oral Anticoagulants Drugs Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Novel Oral Anticoagulants Drugs Price by Type (2016-2021e) & (USD/MT)
Table 41. Global Novel Oral Anticoagulants Drugs Price by Type (2021-2026) & (USD/MT)
Table 42. Global Novel Oral Anticoagulants Drugs Sales by Application (2016-2021e) & (K MT)
Table 43. Global Novel Oral Anticoagulants Drugs Sales by Application (2021-2026) & (K MT)
Table 44. Global Novel Oral Anticoagulants Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Novel Oral Anticoagulants Drugs Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Novel Oral Anticoagulants Drugs Price by Application (2016-2021e) & (USD/MT)
Table 47. Global Novel Oral Anticoagulants Drugs Price by Application (2021-2026) & (USD/MT)
Table 48. North America Novel Oral Anticoagulants Drugs Sales by Country (2016-2021e) & (K MT)
Table 49. North America Novel Oral Anticoagulants Drugs Sales by Country (2021-2026) & (K MT)
Table 50. North America Novel Oral Anticoagulants Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Novel Oral Anticoagulants Drugs Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Novel Oral Anticoagulants Drugs Sales by Type (2016-2021e) & (K MT)
Table 53. North America Novel Oral Anticoagulants Drugs Sales by Type (2021-2026) & (K MT)
Table 54. North America Novel Oral Anticoagulants Drugs Sales by Application (2016-2021e) & (K MT)
Table 55. North America Novel Oral Anticoagulants Drugs Sales by Application (2021-2026) & (K MT)
Table 56. Europe Novel Oral Anticoagulants Drugs Sales by Country (2016-2021e) & (K MT)
Table 57. Europe Novel Oral Anticoagulants Drugs Sales by Country (2021-2026) & (K MT)
Table 58. Europe Novel Oral Anticoagulants Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Novel Oral Anticoagulants Drugs Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Novel Oral Anticoagulants Drugs Sales by Type (2016-2021e) & (K MT)
Table 61. Europe Novel Oral Anticoagulants Drugs Sales by Type (2021-2026) & (K MT)
Table 62. Europe Novel Oral Anticoagulants Drugs Sales by Application (2016-2021e) & (K MT)
Table 63. Europe Novel Oral Anticoagulants Drugs Sales by Application (2021-2026) & (K MT)
Table 64. Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Region (2016-2021e) & (K MT)
Table 65. Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Region (2021-2026) & (K MT)
Table 66. Asia-Pacific Novel Oral Anticoagulants Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Novel Oral Anticoagulants Drugs Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Type (2016-2021e) & (K MT)
Table 69. Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Type (2021-2026) & (K MT)
Table 70. Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Application (2016-2021e) & (K MT)
Table 71. Asia-Pacific Novel Oral Anticoagulants Drugs Sales by Application (2021-2026) & (K MT)
Table 72. South America Novel Oral Anticoagulants Drugs Sales by Country (2016-2021e) & (K MT)
Table 73. South America Novel Oral Anticoagulants Drugs Sales by Country (2021-2026) & (K MT)
Table 74. South America Novel Oral Anticoagulants Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Novel Oral Anticoagulants Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Novel Oral Anticoagulants Drugs Sales by Type (2016-2021e) & (K MT)
Table 77. South America Novel Oral Anticoagulants Drugs Sales by Type (2021-2026) & (K MT)
Table 78. South America Novel Oral Anticoagulants Drugs Sales by Application (2016-2021e) & (K MT)
Table 79. South America Novel Oral Anticoagulants Drugs Sales by Application (2021-2026) & (K MT)
Table 80. Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Country (2016-2021e) & (K MT)
Table 81. Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Country (2021-2026) & (K MT)
Table 82. Middle East & Africa Novel Oral Anticoagulants Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Novel Oral Anticoagulants Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Type (2016-2021e) & (K MT)
Table 85. Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Type (2021-2026) & (K MT)
Table 86. Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Application (2016-2021e) & (K MT)
Table 87. Middle East & Africa Novel Oral Anticoagulants Drugs Sales by Application (2021-2026) & (K MT)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Novel Oral Anticoagulants Drugs Typical Distributors
Table 91. Novel Oral Anticoagulants Drugs Typical Customers
List of Figures
Figure 1. Novel Oral Anticoagulants Drugs Picture
Figure 2. Global Novel Oral Anticoagulants Drugs Sales Market Share by Type in 2020
Figure 3. Direct Thrombin Inhibitor
Figure 4. Factor Xa Inhibitors
Figure 5. Global Novel Oral Anticoagulants Drugs Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drugs Stores
Figure 8. Other
Figure 9. Global Novel Oral Anticoagulants Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Novel Oral Anticoagulants Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Novel Oral Anticoagulants Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Novel Oral Anticoagulants Drugs Sales (2016-2026) & (K MT)
Figure 31. Global Novel Oral Anticoagulants Drugs Production Capacity (2016-2026) & (K MT)
Figure 32. Global Novel Oral Anticoagulants Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Novel Oral Anticoagulants Drugs Market Drivers
Figure 34. Novel Oral Anticoagulants Drugs Market Restraints
Figure 35. Novel Oral Anticoagulants Drugs Market Trends
Figure 36. Global Novel Oral Anticoagulants Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Novel Oral Anticoagulants Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Novel Oral Anticoagulants Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Novel Oral Anticoagulants Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Novel Oral Anticoagulants Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Novel Oral Anticoagulants Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Novel Oral Anticoagulants Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Novel Oral Anticoagulants Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Novel Oral Anticoagulants Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Novel Oral Anticoagulants Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Novel Oral Anticoagulants Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Novel Oral Anticoagulants Drugs Price by Type (2016-2026) & (USD/MT)
Figure 51. Global Novel Oral Anticoagulants Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Novel Oral Anticoagulants Drugs Price by Application (2016-2026) & (USD/MT)
Figure 54. North America Novel Oral Anticoagulants Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Novel Oral Anticoagulants Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Novel Oral Anticoagulants Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Novel Oral Anticoagulants Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Novel Oral Anticoagulants Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Novel Oral Anticoagulants Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Novel Oral Anticoagulants Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Novel Oral Anticoagulants Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Novel Oral Anticoagulants Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Novel Oral Anticoagulants Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Novel Oral Anticoagulants Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Novel Oral Anticoagulants Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Novel Oral Anticoagulants Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Novel Oral Anticoagulants Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
メトトレキサート薬口径薬の世界市場2018-2025 Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.In 2018, the global Methotrexate Oral Solution Drugs market size was xx million US$ and is forec…- メルカプトプリン経口液剤の世界市場2018-2025 Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. In 2018, the global Mercaptopurine Oral Solution Drugs market size was xx million US$ and is forecast to xx million US in 202…
- 世界の経口避妊薬市場 2021：企業別、地域別、種類・用途別 The Oral Contraceptive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 全身性エリテマトーデス（SLE）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …
- 口腔粘膜炎用医薬品の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemoth…